Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β
Liver receptor homolog-1 (LRH-1) is an orphan nuclear receptor that belongs to the NR5A subgroup of nuclear receptors. LRH-1 induces key genes to regulate metabolic process, ovarian function, cancer cell proliferation, and steroidogenesis. In the breast, LRH-1 modulates and synergizes with endogenous estrogen signaling to promote breast cancer cell proliferation. We used small interfering RNA knockdown strategies to deplete LRH-1 in breast cancer cells and followed with microarray analysis to identify LRH-1-dependent mechanisms. We identified key genes involved in TGF-β signaling to be highly responsive to LRH-1 knockdown. This relationship was validated in 2 breast cancer cell lines overexpressing LRH-1 in vitro and in a novel transgenic mouse with targeted LRH-1 overexpression in mammary epithelial cells. Notably, TGF-β signaling was activated in LRH-1-overexpressing breast cancer cells and mouse mammary glands. Further analyses of mammary gross morphology revealed a significant reduction in mammary lateral budding after LRH-1 overexpression. These findings suggest that the altered mammary morphogenesis in LRH-1 transgenic animals is mediated via enhanced TGF-β expression. The regulation of TGF-β isoforms and SMAD2/3-mediated downstream signaling by LRH-1 also implicates a potential contribution of LRH-1 in breast cancer. Collectively, these data demonstrate that LRH-1 regulates TGF-β expression and downstream signaling in mouse mammary glands.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:155 |
---|---|
Enthalten in: |
Endocrinology - 155(2014), 5 vom: 07. Mai, Seite 1606-17 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lazarus, Kyren A [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 16.06.2014 Date Revised 21.04.2014 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1210/en.2013-1948 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM235802352 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM235802352 | ||
003 | DE-627 | ||
005 | 20231224104157.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1210/en.2013-1948 |2 doi | |
028 | 5 | 2 | |a pubmed24n0786.xml |
035 | |a (DE-627)NLM235802352 | ||
035 | |a (NLM)24564400 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lazarus, Kyren A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.06.2014 | ||
500 | |a Date Revised 21.04.2014 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Liver receptor homolog-1 (LRH-1) is an orphan nuclear receptor that belongs to the NR5A subgroup of nuclear receptors. LRH-1 induces key genes to regulate metabolic process, ovarian function, cancer cell proliferation, and steroidogenesis. In the breast, LRH-1 modulates and synergizes with endogenous estrogen signaling to promote breast cancer cell proliferation. We used small interfering RNA knockdown strategies to deplete LRH-1 in breast cancer cells and followed with microarray analysis to identify LRH-1-dependent mechanisms. We identified key genes involved in TGF-β signaling to be highly responsive to LRH-1 knockdown. This relationship was validated in 2 breast cancer cell lines overexpressing LRH-1 in vitro and in a novel transgenic mouse with targeted LRH-1 overexpression in mammary epithelial cells. Notably, TGF-β signaling was activated in LRH-1-overexpressing breast cancer cells and mouse mammary glands. Further analyses of mammary gross morphology revealed a significant reduction in mammary lateral budding after LRH-1 overexpression. These findings suggest that the altered mammary morphogenesis in LRH-1 transgenic animals is mediated via enhanced TGF-β expression. The regulation of TGF-β isoforms and SMAD2/3-mediated downstream signaling by LRH-1 also implicates a potential contribution of LRH-1 in breast cancer. Collectively, these data demonstrate that LRH-1 regulates TGF-β expression and downstream signaling in mouse mammary glands | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a NR5A2 protein, human |2 NLM | |
650 | 7 | |a Neoplasm Proteins |2 NLM | |
650 | 7 | |a Nr5a2 protein, mouse |2 NLM | |
650 | 7 | |a Protein Isoforms |2 NLM | |
650 | 7 | |a Receptors, Cytoplasmic and Nuclear |2 NLM | |
650 | 7 | |a Recombinant Proteins |2 NLM | |
650 | 7 | |a Smad Proteins, Receptor-Regulated |2 NLM | |
650 | 7 | |a Transforming Growth Factor beta |2 NLM | |
700 | 1 | |a Brown, Kristy A |e verfasserin |4 aut | |
700 | 1 | |a Young, Morag J |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Zhe |e verfasserin |4 aut | |
700 | 1 | |a Coulson, Rhiannon S |e verfasserin |4 aut | |
700 | 1 | |a Chand, Ashwini L |e verfasserin |4 aut | |
700 | 1 | |a Clyne, Colin D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Endocrinology |d 1945 |g 155(2014), 5 vom: 07. Mai, Seite 1606-17 |w (DE-627)NLM000002895 |x 1945-7170 |7 nnns |
773 | 1 | 8 | |g volume:155 |g year:2014 |g number:5 |g day:07 |g month:05 |g pages:1606-17 |
856 | 4 | 0 | |u http://dx.doi.org/10.1210/en.2013-1948 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 155 |j 2014 |e 5 |b 07 |c 05 |h 1606-17 |